These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29956730)

  • 1. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma.
    Shi C; Guan Y; Zeng L; Liu G; Zhu Y; Xu H; Lu Y; Liu J; Guo J; Feng X; Zhao X; Jiang W; Li G; Li G; Dai Y; Jin F; Li W; Zhou W
    Int J Oncol; 2018 Sep; 53(3):1138-1148. PubMed ID: 29956730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1.
    Zhou TJ; Zhang SL; He CY; Zhuang QY; Han PY; Jiang SW; Yao H; Huang YJ; Ling WH; Lin YC; Lin ZN
    Theranostics; 2017; 7(5):1389-1406. PubMed ID: 28435473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
    BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High COX-2 expression in cancer-associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma.
    Zhu Y; Shi C; Zeng L; Liu G; Jiang W; Zhang X; Chen S; Guo J; Jian X; Ouyang J; Xia J; Kuang C; Fan S; Wu X; Wu Y; Zhou W; Guan Y
    Mol Carcinog; 2020 Mar; 59(3):265-280. PubMed ID: 31867776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
    Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
    Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.
    Hsu CH; Chen CL; Hong RL; Chen KL; Lin JF; Cheng AL
    Oncology; 2002; 62(4):305-12. PubMed ID: 12138237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 9. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
    Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
    Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effusanin E suppresses nasopharyngeal carcinoma cell growth by inhibiting NF-κB and COX-2 signaling.
    Zhuang M; Zhao M; Qiu H; Shi D; Wang J; Tian Y; Lin L; Deng W
    PLoS One; 2014; 9(10):e109951. PubMed ID: 25333664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb-bud and Heart (LBH) functions as a tumor suppressor of nasopharyngeal carcinoma by inducing G1/S cell cycle arrest.
    Liu Q; Guan X; Lv J; Li X; Wang Y; Li L
    Sci Rep; 2015 Jan; 5():7626. PubMed ID: 25557837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
    Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
    FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.
    Chen RH; Du Y; Han P; Wang HB; Liang FY; Feng GK; Zhou AJ; Cai MY; Zhong Q; Zeng MS; Huang XM
    Oncotarget; 2016 Mar; 7(13):16910-22. PubMed ID: 26919245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
    Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
    J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.